drugset / Trial / NCT01304901

Effect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children.

NCT01304901

Phase 4 Completed 80 enrolled Kecioren Education and Training Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if adding single dose of oral montelukast to the standard treatment of systemic glucocorticoids plus short acting beta-2 agonist for treatment of acute wheezing provide additional clinical benefit in the emergency room.

Timeline

Start
2010-04
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 4 mg Oral

Indications